BPC-157 + TB-500 Blend is supplied in a lyophilized vial format for laboratory research workflows. Available in 5mg/5mg and 10mg/10mg strengths with lot-coded traceability and tamper-evident packaging.
| Strength | Lot # | BPC-157 | TB-500 | Tested |
|---|---|---|---|---|
| 5mg/5mg | PA-2025-032 | 5.37mg; 5.50mg | 6.63mg; 6.92mg | Jun 24, 2025 |
| 10mg/10mg | PA-2026-002 | 12.54mg | 11.87mg | Jun 11, 2026 |
BPC-157 + TB-500 Blend is supplied in a lyophilized vial format for laboratory research workflows. Available in 5mg/5mg and 10mg/10mg strengths with lot-coded traceability and tamper-evident packaging.
| Strength | Lot # | BPC-157 | TB-500 | Tested |
|---|---|---|---|---|
| 5mg/5mg | PA-2025-032 | 5.37mg; 5.50mg | 6.63mg; 6.92mg | Jun 24, 2025 |
| 10mg/10mg | PA-2026-002 | 12.54mg | 11.87mg | Jun 11, 2026 |
The BPC-157 & TB-500 Blend combines two extensively studied research peptides in a single lyophilized vial for laboratory research applications. Available in 5mg/5mg and 10mg/10mg strength combinations, each vial includes lot-based traceability and tamper-evident packaging for consistent laboratory research workflows.
This product combines BPC-157, a gastric-protective-protein-derived pentadecapeptide, with TB-500 (Thymosin Beta-4), an actin-sequestering peptide, in a single vial for combined tissue-repair research.
A lyophilized (freeze-dried) powder in a sealed glass vial, ready for reconstitution per your lab’s protocol.
Every vial carries an internal lot code tied to our traceability log, plus tamper-evident sealing maintained from fulfillment through delivery.
No. This product is sold strictly for laboratory research use by qualified researchers, and is not a drug, dietary supplement, or medical device.
Certificate of analysis documentation is available for both strength combinations, with results published to the product page and broken out by compound.
Orders are prepared from lot-tracked inventory and shipped in tamper-evident packaging with tracking information.
| Size | 5mg/5mg, 10mg/10mg |
|---|